The aim of the present study is the systematic and critical investigation of the effectiveness of fennel on the climacteric symptoms among menopausal females. Methods: A search of the trials studying the effect of fennel on menopausal females was conducted in 2017 using the MEDLINE and Scopus databases and the Cochrane Library with the following keywords: fennel, Foeniculum vulgare, and menopause. Results: Fennel combined with officinalis is more effective in the attenuating of sleep disorders compared to Citalopram. The comparison of these two groups regarding the mean bone mineral density and bone mineral content (P = 0.14, P = 0.504); the total hip femoral (P = 0.42, P = 0.66); the trochanter (P = 0.075, P = 0.07); the intertrochanter (P = 0.84, P = 0.93); and the femoral neck (P = 0.43, P = 0.64) did not show any significant statistical differences; however, a statistically significant difference regarding the vasomotor symptoms (P < 0.01) was found. The other significant differences are related to the values of the total cholesterol (P = 0.103); low-density lipoprotein cholesterol, or LDL-C (P = 0.104); high-density lipoprotein cholesterol, or HDL-C (P = 0.266); triglyceride (P = 0.679); body weight (P = 0.212); body mass index (P = 0.041); waist and hip circumferences (P = 0.365); and fat distribution (P = 0.337) between the two groups. The standardized mean difference (SMD) values of sexual activity (SMD = 0.638; P < 0.001), and maturation value (SMD = 0.601; P = 0.003) are highly significant among the fennel-treated women compared with the placebo group. Conclusions: According to the findings of the present study, fennel is important in the relieving of vasomotor symptoms, vaginal itching, dryness, dyspareunia, sexual function, sexual satisfaction, and sleep distribution. (J Menopausal Med 2018;24:67-74)
Introduction
The menopause as a natural biological phenomenon experienced by all women 1~3 refers to the permanent cessation of the menstrual cycle as a result of ovarian dysfunction. 4 The menopause is characterized by estrogen deficiency that is associated with the vaginal atrophy, bone loss, mood variations and hot flashes. 5 One of the major causes of mortality and morbidity in elderly women is osteoporosis that imposes huge financial burden on the society. 6, 7 Among which, there are several complications following the use of chemical medications in treating the osteoporosis; for example, raloxifene that is associated with some adverse effects of vein thrombose and
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Women: A Systematic and Meta-analysis J MM pulmonary embolism. 8 Reportedly, the menopause females frequently suffer from the psychological symptoms such as anxiety and depression 9 ; in this regard, benzodiazepines and antidepressants have a wild therapeutic application for the mood variations among menopausal women, resulting in complications like sleepiness and dependence as well as anticholinergic and cardiotoxic effects. 9 The hormone therapy has shown to protect the bone mass and to improve vasomotor symptoms and vaginal dryness. The hormone replacement therapy lost its therapeutic value due to unexpected side effects reported by the Women' s Health Initiative, such as increased risk of cardiovascular and breast cancer and venous thrombosis. 10, 11 Following the mentioned healthcare concerns, the use of phytoestrogens has attracted further attentions in treating the menopause-related disorders, including fennel (Foeniculum vulgare 15 To the best of our knowledge, this is the first systematic review investigating the fennel effects on the menopause symptoms.
Materials and Methods
The trials studying the effect of fennel on the menopause were searched on databases of MEDLINE, Scopus, Google Scholar, and Cochrane Library (Cochrane Central Register of Controlled Trials) using the keywords of (fennel and Foeniculum vulgare) and menopause in any language in 2017.
The respective publications were identified by manual manner among the references of studies.
Inclusion criteria
The study inclusion criteria were randomized controlled trials (RCTs), postmenopausal women and assessment of the fennel effects on at least one menopausal symptom.
Data extraction
Two separate assessors extracted the data, including sample size, type of intervention and control, duration of treatment, dose and outcomes. Consensus-based discussion eliminated any disagreement (Table 1) .
Assessment of publication bias
Publication bias was measured using Cochrane Collaboration' s 'Risk of bias' tool ( Table 2) .
Statistical analysis
The main effect size was considered to be the standardized main difference (SMD). Pooling studies were performed using a random statistical model. Cochrane Q test (P < 0.05) and I 2 index were calculated to obtain the heterogeneity. The analyses were statistically carried out using a Comprehensive meta-analysis version 2 (Biostat, Englewood, NJ, USA).
Results
Process of studies selections was display in Fig. 1 . In total, 10 studies (five duplicate publications) were included to systematic review. Some studies were reported as qualitative and some other studies that had sufficient information included in meta-analysis. The third trial by Abdali et al. 21 compared three arms:
fennel, Hypericum perforatum and placebo. They conducted a blind placebo-controlled clinical trial on 120 menopausal women. Patients were randomized into one of three groups.
The 33 patients received three tablets Hypericum perforutum (total dose 160 mg of hypiran), 33 patients received three fennel tables per day (total dose 90 mg) and the last 32 patients received three tablet placebo per day. Sexual function was measured using the female sexual function index.
Inter-group comparison showed a significant difference in Hypericum perforutum (P < 0.001), fennel (P < 0.001) and placebo (P < 0.001) across three-time interval (baseline, 4
Detected relevant studies in the first search n = 592
Non-relevant studies excluded by reading titles and abstracts n = 577
Studies included in the review systematic n = 10 (5 duplication publications) In the meta analysis psychological symptoms n = 2 Sexual activity n = 3 Vaginal atrophy n = 2
Non-relevant studies when they assessed in detail n = 5
Studies assessed in detail n = 15 was not significant at baseline (P = 0.172) and week 4 (P = 0.477). Both fennel (P = 0.012) and Hypericum perforutum (P = 0.029) were difference from placebo at week 8. 21 Combining the finding of these three studies through random effect model reveal that pooled SMD of sexual activity was highly significant than in women treated with fennel compared to placebo (SMD = 0.611; P < 0.001; 95% CI, 0.330-0.839; heterogeneity; I 2 = 57.58, P = 0.095) (Fig. 3) .
The effect of fennel on vasomotor symptom
Only one trial by Kian et al. 20 
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comparison between two group was significant (P < 0.01).
20
Combining the finding of two studies through random effect model reveal that pooled SMD of psychological symptoms was not significant (pooled SMD = -0.492, P = 0.197, 95%
CI, -1.23 to 0.256). However heterogeneity was significant (I 2 = 76, P = 0.03) between two studies (Fig. 4) . 
Discussion
As far as know, this is the first study to assess the fennel effect on the menopausal women' s health. According to two trials, both routes (oral and topical) had positive effect on vaginal epithelium. However, the fennel had more effect when it applied topically. Based on the two trials, 3 
Conclusion
According to the findings, the fennel had been reported important in relieving the vasomotor symptom, vaginal itching and dryness, dyspareunia, sexual function, sexual satisfaction and sleep distribution. Fennel may have the limited positive effect in patients with depression or anxiety disorder but not healthy women. There were no effect on body weight and fat distribution, bone density and lipid profiles. However, these conclusions should be claimed cautiously because of small sample size, limited studies, high placebo effect and lack of physical and nutritional assessments duration treatment.
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